mhurhangee/patent-ind-claim-en huggingface dataset:
Device for using wind energy comprising: • a buoyancy body in order to generate a lifting force by a lifting gas supplied to the buoyancy body in order to set the buoyancy body into a flying state wherein the buoyancy body extends in a longitudinal direction (L); • at least two rotors which are mounted in rotatable manner in the longitudinal direction (L) at the opposite ends of the buoyancy body in order to transmit their rotational movement to a generator shaft of a generator in order to generate power; • wherein the buoyancy body has a casing for protection against weathering and/or for storing the lifting gas which comprises in particular at least two lifting gas cells for receiving the lifting gas, and has a supporting structure in order to hold the casing in a dimensionally stable condition and to provide a holder for the rotors ; • characterized in that the supporting structure comprises at least two sub-structures which each form a helix structure wherein the sub-structures are oriented coaxially and each have an opposite winding direction to one another. • a buoyancy body in order to generate a lifting force by a lifting gas supplied to the buoyancy body in order to set the buoyancy body into a flying state wherein the buoyancy body extends in a longitudinal direction (L); • at least two rotors which are mounted in rotatable manner in the longitudinal direction (L) at the opposite ends of the buoyancy body in order to transmit their rotational movement to a generator shaft of a generator in order to generate power; • wherein the buoyancy body has a casing for protection against weathering and/or for storing the lifting gas which comprises in particular at least two lifting gas cells for receiving the lifting gas, and has a supporting structure in order to hold the casing in a dimensionally stable condition and to provide a holder for the rotors ; • characterized in that the supporting structure comprises at least two sub-structures which each form a helix structure wherein the sub-structures are oriented coaxially and each have an opposite winding direction to one another.
A compressor assembly , comprising: a compressor case disposed about an axis (A-A'); a bleed valve disposed about the compressor case and configured to axially translate and/or rotationally move relative to the compressor case; a first seal disposed in a forward seal housing of the bleed valve, wherein the first seal is disposed at a first radial distance (R 1 ) from the axis; a first sealing wall fixed relative to the compressor case and configured to engage the first seal; a second seal disposed in an aft seal housing of the bleed valve, wherein the second seal is disposed at a second radial distance (R 2 ) from the axis; and a second sealing wall fixed relative to the compressor case and configured to engage the second seal; characterized in that ; the first radial distance is substantially equal to the second radial distance such that net bias loads on the bleed valve in the forward/aft directions are minimized. a compressor case disposed about an axis (A-A'); a bleed valve disposed about the compressor case and configured to axially translate and/or rotationally move relative to the compressor case; a first seal disposed in a forward seal housing of the bleed valve, wherein the first seal is disposed at a first radial distance (R 1 ) from the axis; a first sealing wall fixed relative to the compressor case and configured to engage the first seal; a second seal disposed in an aft seal housing of the bleed valve, wherein the second seal is disposed at a second radial distance (R 2 ) from the axis; and a second sealing wall fixed relative to the compressor case and configured to engage the second seal; characterized in that ; the first radial distance is substantially equal to the second radial distance such that net bias loads on the bleed valve in the forward/aft directions are minimized.
DC-DC voltage converter for converting an input DC voltage (U_in) into a predetermined output DC voltage (U_out), comprising: a DC-DC converter which is designed to convert an input DC voltage (U_in) into the output DC voltage (U_out), and a comparison means which is designed to provide a controlled variable (R1), based on a comparison of a value of the output DC voltage (U_out) of the DC-DC voltage converter with a predetermined setpoint voltage value (U_setpoint) for the output DC voltage (U_out); characterized by a correction means which is designed to adjust a value of the input DC voltage (U_in) of the DC-DC voltage converter , based on a previously determined correction function, and to output the value (U_in,cor) of the adjusted input DC voltage; wherein the correction means is furthermore designed to receive the first controlled variable (R1) and to adjust the correction function if the first controlled variable (R1) is detected in a stationary mode; a regulating means which is designed to compare the value (U_in,cor) of the adjusted input DC voltage and the predetermined setpoint voltage value (U_setpoint) for the output DC voltage (U_out) with one another and to calculate an additional controlled variable (R2) therefrom; and a calculating means which is designed to calculate a regulator value (R3) from the controlled variable (R1) of the comparison means and the additional controlled variable (R2) of the regulating means ; wherein the DC-DC converter is designed to convert the input DC voltage (U_in) into the output DC voltage (U_out) based on the regulator value (R3) calculated by the calculating means . a DC-DC converter which is designed to convert an input DC voltage (U_in) into the output DC voltage (U_out), and a comparison means which is designed to provide a controlled variable (R1), based on a comparison of a value of the output DC voltage (U_out) of the DC-DC voltage converter with a predetermined setpoint voltage value (U_setpoint) for the output DC voltage (U_out); characterized by a correction means which is designed to adjust a value of the input DC voltage (U_in) of the DC-DC voltage converter , based on a previously determined correction function, and to output the value (U_in,cor) of the adjusted input DC voltage; wherein the correction means is furthermore designed to receive the first controlled variable (R1) and to adjust the correction function if the first controlled variable (R1) is detected in a stationary mode; a regulating means which is designed to compare the value (U_in,cor) of the adjusted input DC voltage and the predetermined setpoint voltage value (U_setpoint) for the output DC voltage (U_out) with one another and to calculate an additional controlled variable (R2) therefrom; and a calculating means which is designed to calculate a regulator value (R3) from the controlled variable (R1) of the comparison means and the additional controlled variable (R2) of the regulating means ; wherein the DC-DC converter is designed to convert the input DC voltage (U_in) into the output DC voltage (U_out) based on the regulator value (R3) calculated by the calculating means .
An inhaler device for controlled extraction of at least one active substance from at least one type of plant matter by application of heat, said inhaler device comprising: a source material layer containing plant matter; a material layer in contact with said source material layer; circuitry for controlling heating of said plant matter; a delivery tract for delivery of said active substance to a user; characterized in that said material layer is configured for direct heating of said plant matter to extract said active substance; said material layer comprising apertures having a size sufficiently small to contain said plant matter and sufficiently large to allow said active substance to escape to a delivery tract; and in that said source material layer has a thickness ranging from 0.2 mm to 1 mm; said source material layer compressed to a density that leaves enough air spaces for vapors to escape, so that at least some air flows from behind said layer, through said layer, and to said delivery tract. a source material layer containing plant matter; a material layer in contact with said source material layer; circuitry for controlling heating of said plant matter; a delivery tract for delivery of said active substance to a user; characterized in that said material layer is configured for direct heating of said plant matter to extract said active substance; said material layer comprising apertures having a size sufficiently small to contain said plant matter and sufficiently large to allow said active substance to escape to a delivery tract; and in that said source material layer has a thickness ranging from 0.2 mm to 1 mm; said source material layer compressed to a density that leaves enough air spaces for vapors to escape, so that at least some air flows from behind said layer, through said layer, and to said delivery tract.
A pharmaceutical composition, comprising a sulfonylurea drug, a cyclodextrin and an additive; wherein said additive is selected from sodium carbonate, sodium hydrogen carbonate, sodium borate, sodium hydroxide, potassium hydroxide, disodium hydrogen phosphate, sodium dihydrogen phosphate, sodium dihydrogen citrate, sodium monohydrogen citrate, sodium citrate, meglumine, Tris(hydroxymethyl)aminomethane, monoethanolamine, diethanolamine, lysine, arginine and histidine; wherein the pharmaceutical composition has a weight ratio of said sulfonylurea drug to said cyclodextrin of 1:25∼1000; wherein the pharmaceutical composition has a weight ratio of said sulfonylurea drug to said additive of 1:0.5∼100; wherein said sulfonylurea drug is glibenclamide; wherein the pharmaceutical composition is an injection. wherein said additive is selected from sodium carbonate, sodium hydrogen carbonate, sodium borate, sodium hydroxide, potassium hydroxide, disodium hydrogen phosphate, sodium dihydrogen phosphate, sodium dihydrogen citrate, sodium monohydrogen citrate, sodium citrate, meglumine, Tris(hydroxymethyl)aminomethane, monoethanolamine, diethanolamine, lysine, arginine and histidine; wherein the pharmaceutical composition has a weight ratio of said sulfonylurea drug to said cyclodextrin of 1:25∼1000; wherein the pharmaceutical composition has a weight ratio of said sulfonylurea drug to said additive of 1:0.5∼100; wherein said sulfonylurea drug is glibenclamide; wherein the pharmaceutical composition is an injection.
A control network entity for an LTE network , the control network entity comprising a first control entity and a second control entity , wherein the first control entity is configured to control a first packet processing engine, PPE, and the second control entity is configured to control a second packet processing engine, PPE, , the said first PPE and the said second PPE being located outside a core network of the LTE network , such that user plane traffic is routed through the said first PPE and the said second PPE ; the first control entity is configured to route a dedicated bearer request to the second control entity rather than to a central gateway entity ; the second control entity is configured to accept the dedicated bearer request routed to it by the first control entity such that a dedicated bearer terminating at the second control entity can be set up without first setting up a default bearer terminating at the second control entity , wherein the dedicated bearer is a child of the default bearer, the dedicated bearer having specific quality of service properties for carrying voice or video data; and the first control entity and the second control entity are located within the core network of the LTE network . the first control entity is configured to route a dedicated bearer request to the second control entity rather than to a central gateway entity ; the second control entity is configured to accept the dedicated bearer request routed to it by the first control entity such that a dedicated bearer terminating at the second control entity can be set up without first setting up a default bearer terminating at the second control entity , wherein the dedicated bearer is a child of the default bearer, the dedicated bearer having specific quality of service properties for carrying voice or video data; and the first control entity and the second control entity are located within the core network of the LTE network .
Method (S1-S7) for operating a household steam treatment appliance with a steam treatment compartment and with a steam generator which is arranged outside of the steam treatment compartment and connected to a water tank , wherein, with the method a) water (W) is heated to an increased preheating temperature below an evaporation temperature (S3) by means of the steam generator , b) the water (W) is kept at the preheating temperature (S4) and c) in response to an instruction to introduce water vapour (D) (S5), the water (W) in the steam generator is further heated to an evaporation temperature and the generated water vapour (D) is introduced into the steam treatment compartment (S6), wherein the water vapour (D) is introduced (S6) in the form of at least one steam jet. a) water (W) is heated to an increased preheating temperature below an evaporation temperature (S3) by means of the steam generator , b) the water (W) is kept at the preheating temperature (S4) and c) in response to an instruction to introduce water vapour (D) (S5), the water (W) in the steam generator is further heated to an evaporation temperature and the generated water vapour (D) is introduced into the steam treatment compartment (S6), wherein the water vapour (D) is introduced (S6) in the form of at least one steam jet.
A work device which performs a work with use of an end effector and has six degrees of freedom, the work device comprising: a linear motion unit obtained by combining three linear motion actuators , to have three degrees of freedom; and a rotation unit obtained by combining a plurality of rotation mechanisms each having one or more degrees of rotational freedom, to have three degrees of freedom, wherein a base portion of the linear motion unit is fixed to a mount of the work device , a base portion of the rotation unit is fixed to an output portion of the linear motion unit , and the end effector is mounted to an output portion of the rotation unit , characterized in that an attachment angle of the base portion of the rotation unit relative to the output portion of the linear motion unit is changeable. a linear motion unit obtained by combining three linear motion actuators , to have three degrees of freedom; and a rotation unit obtained by combining a plurality of rotation mechanisms each having one or more degrees of rotational freedom, to have three degrees of freedom, wherein a base portion of the linear motion unit is fixed to a mount of the work device , a base portion of the rotation unit is fixed to an output portion of the linear motion unit , and the end effector is mounted to an output portion of the rotation unit ,
A system for treating an ischemic event, comprising: a first reperfusion device for restoring perfusion to an occluded vessel having a clot; a second reperfusion device for restoring perfusion to the occluded vessel having the clot; a delivery system for delivering at least one of the first and second reperfusion devices to the clot in the occluded vessel, the delivery system including at least one of a catheter and a guidewire; and a clot analysis system analyzing the clot of the occluded vessel and determining an individualized treatment protocol using at least one of the first and the second reperfusion devices; wherein the first reperfusion device is a stent retriever and the second reperfusion device is a pinch retriever; and wherein the clot analysis system comprises one of: (a) the catheter of the delivery system, the catheter including a lumen having a proximal end and a distal end; and a spectroscopic mechanism for analyzing clot composition at a site of the clot in the vasculature; and (b) the guidewire of the delivery system, the guidewire including one or more sensors configured for sensing properties of the clot in vivo and treating the clot based on the sensed properties. a first reperfusion device for restoring perfusion to an occluded vessel having a clot; a second reperfusion device for restoring perfusion to the occluded vessel having the clot; a delivery system for delivering at least one of the first and second reperfusion devices to the clot in the occluded vessel, the delivery system including at least one of a catheter and a guidewire; and a clot analysis system analyzing the clot of the occluded vessel and determining an individualized treatment protocol using at least one of the first and the second reperfusion devices; wherein the first reperfusion device is a stent retriever and the second reperfusion device is a pinch retriever; and wherein the clot analysis system comprises one of: (a) the catheter of the delivery system, the catheter including a lumen having a proximal end and a distal end; and a spectroscopic mechanism for analyzing clot composition at a site of the clot in the vasculature; and (b) the guidewire of the delivery system, the guidewire including one or more sensors configured for sensing properties of the clot in vivo and treating the clot based on the sensed properties. (a) the catheter of the delivery system, the catheter including a lumen having a proximal end and a distal end; and a spectroscopic mechanism for analyzing clot composition at a site of the clot in the vasculature; and (b) the guidewire of the delivery system, the guidewire including one or more sensors configured for sensing properties of the clot in vivo and treating the clot based on the sensed properties.
A production method of a semiconductor device, comprising the following method steps: - providing a semiconductor substrate ; - forming a functional layer on a semiconductor surface of the semiconductor substrate ; and - generating at least one doping area at the semiconductor surface by feeding a doping material from the functional layer into the semiconductor substrate , wherein the functional layer is formed in such a way that it passivates upon completion of the semiconductor device the semiconductor surface as a passivation layer, characterized in that the functional layer is made of aluminum oxide (AlO x ), titanium oxide (TiOx), magnesium oxide (MgOx) or zinc oxide (ZnOx) and aluminum, titanium, magnesium or zinc of the compound serves correspondingly as doping material. - providing a semiconductor substrate ; - forming a functional layer on a semiconductor surface of the semiconductor substrate ; and - generating at least one doping area at the semiconductor surface by feeding a doping material from the functional layer into the semiconductor substrate , wherein the functional layer is formed in such a way that it passivates upon completion of the semiconductor device the semiconductor surface as a passivation layer, characterized in that the functional layer is made of aluminum oxide (AlO x ), titanium oxide (TiOx), magnesium oxide (MgOx) or zinc oxide (ZnOx) and aluminum, titanium, magnesium or zinc of the compound serves correspondingly as doping material.
A filling machine configured to fill containers with a pourable product, comprising: - a conveyor , the machine being configured so that the conveyor sequentially receives containers to be filled at an input station (I) thereof, sequentially advances the received containers along a filling path, and sequentially releases the filled containers at an output station (O) thereof; - a plurality of filling devices carried by the conveyor , each filling device comprising a respective filling valve and being configured for delivering the product to at least one container to be filled at a time, during the advancement of at least one container to be filled along the filling path and by means of the respective filling valve being in an open position, the filling valve of each filling device being controllable between the respective open position and a respective closed position; - a control unit ; wherein the machine is configured so that, for each filling device : - the filling device receives cyclically at least one container to be filled, when the filling device is at the input station I; characterized in that the control unit cyclically sends an opening control signal for triggering the opening of the respective filling valve with an advance time before the filling device receives the at least one container to be filled. - a conveyor , the machine being configured so that the conveyor sequentially receives containers to be filled at an input station (I) thereof, sequentially advances the received containers along a filling path, and sequentially releases the filled containers at an output station (O) thereof; - a plurality of filling devices carried by the conveyor , each filling device comprising a respective filling valve and being configured for delivering the product to at least one container to be filled at a time, during the advancement of at least one container to be filled along the filling path and by means of the respective filling valve being in an open position, the filling valve of each filling device being controllable between the respective open position and a respective closed position; - a control unit ; wherein the machine is configured so that, for each filling device : - the filling device receives cyclically at least one container to be filled, when the filling device is at the input station I;
A valveless spacer device for an MDI, the spacer device comprising: a body having an inlet comprising a mount defining an inlet passage for sealingly engaging with a mouthpiece of an MDI and an outlet opposed from the inlet in which the outlet comprises a mouthpiece defining an outlet passage; 5 a demountable, flexible bag attached to the body , the bag and body together defining a chamber , such that the inlet and outlet are in fluid flow communication with an interior of the chamber ; wherein the inlet is configured to be connected to an MDI containing a drug to be inhaled; wherein the outlet is configured to be received by a user's mouth; and wherein the flexible bag , following actuation of the MDI, serves as a reservoir allowing for the formation of a cloud or mist of the drug therewithin which is then ready for inhalation, the flexible bag being configured to be at least partially deflatable and at least partially inflatable commensurate with a single breath and/or rebreathing; characterized in that the body is in the form of a generally V-shaped mounting which is formed by the opposing inlet passage and the outlet passage intersecting at an angle along their respective longitudinal axes. a body having an inlet comprising a mount defining an inlet passage for sealingly engaging with a mouthpiece of an MDI and an outlet opposed from the inlet in which the outlet comprises a mouthpiece defining an outlet passage; 5 a demountable, flexible bag attached to the body , the bag and body together defining a chamber , such that the inlet and outlet are in fluid flow communication with an interior of the chamber ; wherein the inlet is configured to be connected to an MDI containing a drug to be inhaled; wherein the outlet is configured to be received by a user's mouth; and wherein the flexible bag , following actuation of the MDI, serves as a reservoir allowing for the formation of a cloud or mist of the drug therewithin which is then ready for inhalation, the flexible bag being configured to be at least partially deflatable and at least partially inflatable commensurate with a single breath and/or rebreathing; characterized in that the body is in the form of a generally V-shaped mounting which is formed by the opposing inlet passage and the outlet passage intersecting at an angle along their respective longitudinal axes.